Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...
The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the ...
On January 13, 2025, the California AG’s Office (“AGO”) issued two legal advisories regarding the application of existing California law to ...
NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...
Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...
The rationale for asking about mental health was to ensure patient safety ... also recommended updates to licensure application forms. The foundation is a physician mental health advocacy nonprofit ...
January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...
FAIRHOPE, Ala. ( WALA) - Thomas Hospital broke ground Wednesday on its new patient tower. Hailed as a significant milestone, ...
As artificial intelligence rapidly gains prominence and sophistication, health care professionals in Rhode Island have been ...
GRAND FORKS, N.D. (Valley News Live) - Altru Health System leaders announced all patients have been transferred safely from the old hospital into the new one over the weekend. They are offering a ...
Basal cell carcinomas, the most common form ... in patients for whom major surgery should be avoided. Further studies are to follow in order to confirm the benefits of this new option in a larger ...